Patents by Inventor Yingyun Wu

Yingyun Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
    Publication number: 20150265698
    Abstract: The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
    Type: Application
    Filed: June 4, 2015
    Publication date: September 24, 2015
    Inventors: Peter PUSHKO, Yingyun Wu, Michael J. Massare, Ye Liu, Gale Smith, Bin Zhou
  • Highly efficient influenza matrix (M1) proteins
    Patent number: 8992939
    Abstract: This invention discloses a method of increasing production of virus-like particles comprising expressing an avian influenza matrix protein. The invention also comprises methods of making and using said VLPs.
    Type: Grant
    Filed: October 24, 2011
    Date of Patent: March 31, 2015
    Assignee: Novavax, Inc.
    Inventors: Gale Smith, Yingyun Wu, Michael Massare, Peter Pushko, Margret Nathan, Thomas Kort, Robin Robinson
  • MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
    Publication number: 20140294879
    Abstract: The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
    Type: Application
    Filed: March 21, 2014
    Publication date: October 2, 2014
    Applicant: NOVAVAX, INC.
    Inventors: Peter PUSHKO, Yingyun WU, Michael J. MASSARE, Ye LIU, Gale SMITH, Bin ZHOU
  • Modified RSV F proteins and methods of their use
    Patent number: 8715692
    Abstract: The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
    Type: Grant
    Filed: December 9, 2009
    Date of Patent: May 6, 2014
    Assignee: Novavax, Inc.
    Inventors: Peter Pushko, Yingyun Wu, Michael Massare, Ye Liu, Gale Smith, Bin Zhou
  • RECOMBINANT NANOPARTICLE RSV F VACCINE FOR RESPIRATORY SYNCYTIAL VIRUS
    Publication number: 20130122032
    Abstract: The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
    Type: Application
    Filed: September 27, 2012
    Publication date: May 16, 2013
    Inventors: Gale SMITH, Yingyun Wu, Michael Massare, Ye Liu
  • HIGHLY EFFICIENT INFLUENZA MATRIX (M1) PROTEINS
    Publication number: 20130039938
    Abstract: This invention discloses a method of increasing production of virus-like particles comprising expressing an avian influenza matrix protein. The invention also comprises methods of making and using said VLPs.
    Type: Application
    Filed: October 24, 2011
    Publication date: February 14, 2013
    Applicant: NOVAVAX, INC.
    Inventors: Gale SMITH, Yingyun Wu, Michael Massare, Peter Pushko, Margret Nathan, Thomas Kort, Robin Robinson
  • MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE
    Publication number: 20100239617
    Abstract: The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
    Type: Application
    Filed: December 9, 2009
    Publication date: September 23, 2010
    Inventors: Peter PUSHKO, Yingyun Wu, Michael Massare, Ye Liu, Gale Smith, Bin Zhou
  • RESPIRATORY SYNCYTIAL VIRUS-VIRUS LIKE PARTICLE (VLPS)
    Publication number: 20080233150
    Abstract: The present invention discloses and claims virus like particles (VLPs) that express and/or contains RSV proteins. The invention includes vector constructs comprising said proteins, cells comprising said constructs, formulations and vaccines comprising VLPs of the inventions. The invention also includes methods of making and administrating VLPs to vertebrates, including methods of inducing immunity to infections, including RSV.
    Type: Application
    Filed: November 16, 2007
    Publication date: September 25, 2008
    Inventors: Gale SMITH, Peter Pushko, Mike Massare, Yingyun Wu, Kutub Mahmood